Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:10:00
Global biotechnology company with a dedicated mission to be at the heart of cancer care|Dr Daniel Tillett,Chief Executive Officer,Race Oncology Ltd
00:10:00
An Emerging Global Leader in the New Generation of Anti-Infective Therapies|James Graham,Managing Director,Recce Ltd
00:10:00
Pioneering Virology Company Aims to Develop Functional Cure for Hepatitis B and Treatments for Coronavirus Infections | William H. Collier, CEO, Arbutus Biopharma Corp.
00:10:00
Exploring the Evolution of Biotechnology: A Journey into RNA Medicines and Scientific Innovation |Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc.
00:10:00
Significant Developments and Growth in Arecor Therapeutics' Operations Highlighted in Year-End Trading Update | Sarah Howell , CEO, Arecor Therapeutics PLC .
00:10:00
Revolutionizing Brain Injury Treatment: Breakthrough Trials Signal Collaborative Potential with Pharma Giants |Dr Liz Dallimore , CEO, Argenica Therapeutics Ltd.
00:10:00
Insights into AORA Biosurgery's innovative soft tissue reconstruction products, growth trajectory, and clinical trials |Brian Ward, CEO, Aroa Biosurgery Ltd .
00:10:00
Advanced cancer therapy shows promising results in licensing agreement announcement |Michael Baker, CEO, Arovella Therapeutics Ltd.
00:10:00
Innovative neuroprotective therapy ARG-007 shows promise in reducing brain cell death post-stroke, poised for phase one clinical trial |Dr Liz Dallimore , CEO, Argenica Therapeutics Ltd.
00:10:00
Empowering Women Leaders: Insights from AlbionVC's Conversation Series with Dr. Sarah Howell | Sarah Howell , CEO, Arecor Therapeutics PLC .
00:10:00
Revolutionizing Therapeutics: Advancements in RNA Medicines|Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc.
00:10:00
"Stories of the Exchange" features CEO of Antibiotice Iași as Guest on TV |Ioan Nani, CEO, Antibiotice Iași.
00:10:00
Insightful interview with a biotech CEO discussing the company's focus on antisense therapies and the potential of their lead asset in treating Duchenne Muscular Dystrophy |James Garner, CEO,Antisense Therapeutics Ltd
00:10:00
Revolutionizing Therapy Adherence: The Single Pill Concept's Impact on Patient Well-being and Healthcare Costs |Karlheinz Gast, CEO, Apontis Pharma.
00:10:00
CEO of Aptamer Group PLC discusses anticipation of higher revenues in the second half following the release of interim results |Dr Arron Tolley, CEO, Aptamer Group PLC.
00:10:00
Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc .
00:10:00
Innovative Drug Delivery System for Patients with Swallowing Difficulties: Aquestive Therapeutics' Approach and Medications in Development | Daniel Barber, CEO, Aquestive Therapeutics Inc.
00:10:00
Our validated technology platform can produce orally active polyclonal antibodies|Steven Lydeamore,Chief Executive Officer,Immuron Ltd
00:10:00
Bringing Effective New Treatments And Options To Patients Who Need Them|Leslie Chong, CEO,Imugene Ltd
00:10:00
Unlocking the therapeutic potential of rare cannabinoids|Eric A. Adams,CEO,InMed Pharmaceuticals Inc

© 2017 - Neuhu+